A man who boosted his Pfizer COVID-19 vaccine with a shot from Moderna said his side effects were a 'little more severe' the third time round
- Scientists in the US are starting a booster shot trial, giving fully vaccinated people another jab.
- Participants are given a booster shot of the
Modernavaccine - whether they previously got 2 shots of an mRNA vaccine (from Pfizer or Moderna) or 1 adenovirus (J&J) shot.
- One participant told Insider his booster dose of Moderna gave him similar side effects to his second Pfizer shot, but the third was "a little bit more severe."
Virus expert Joseph Hyser has been fully vaccinated since the end of January, and he's not really worried that his COVID-19 protection from the Pfizer vaccine has waned much since then.Yet, when he got an email last month asking if he'd be interested in getting a third dose booster shot - this time from Moderna - he did not hesitate to say yes.
View all Offers
OnePlus Nord 2 5G (Blue Haze, 8GB RAM, 128GB Storage) I Extra upto Rs.1000 off on Exchange₹ 29999Buy On
OnePlus Nord 2 5G (Gray Sierra, 8GB RAM, 128GB Storage) I Extra upto Rs.1000 off on Exchange₹ 29999Buy On
- 18% OFF
Redmi 9 (Carbon Black, 4GB RAM, 64GB Storage) | Extra INR 200 Amazon Pay Cashback | 2.3GHz Mediatek Helio G35 Octa core Processor₹ 8999₹ 10999Buy On
- 19% OFF
Redmi Note 10 (Aqua Green, 4GB RAM, 64GB Storage) -Amoled Dot Display | 48MP Sony Sensor IMX582 | Snapdragon 678 Processor₹ 12999₹ 15999Buy On
- 20% OFF
Redmi 9A (Nature Green, 2GB RAM, 32GB Storage) | 2GHz Octa-core Helio G25 Processor | 5000 mAh Battery₹ 6799₹ 8499Buy On
Perhaps they didn't realize that Hyser is one of the first Americans to participate in a groundbreaking COVID-19 mix-and-match study, aimed at assessing whether boosters work, and whether different COVID-19 shots are safe - and possibly more effective - when they're mixed together.Though Hyser says he experienced "similar types of side effects" from both Moderna's and Pfizer's mRNA shots, he said the side effects were "a little bit more obvious with the Moderna."
Is it safe to mix shots from Moderna, Pfizer, and Johnson & Johnson?
This is not Hyser's first vaccine trial, he's been in studies of smallpox shots, anthrax vaccines, and annual flu jabs."I'm a dyed in the wool nerd, so I mean, of course I think that this is interesting," he said of the trial. "I like being involved in being a part of producing
For now, the study is boosting only with a single dose of Moderna's vaccine, whether participants' first shots were from Moderna, or from Pfizer or Johnson & Johnson - the other two US-authorized vaccines. Other combinations of the vaccines, and which order they're taken in, will be added in to the study later on.
Study participants will get routine blood draws (Hyser already had his first), and initial results could be ready within months.A big question this study will explore is whether boosting people who've had J&J's one-shot adenovirus vaccine with Moderna's mRNA shot might make the performance similar. (J&J's vaccine did not protect as well against mild and moderate disease compared to Pfizer and Moderna's two dose mRNA regimens during clinical trials.)
"Is it because of the [vaccine] construct, or is it because of the one dose? We don't really have the answer to that," lead study researcher Dr. Robert Atmar, from the Vaccine Research Center at Baylor, told Insider of J&J's lower efficacy.
A day of chills, body aches, and ibuprofen after the 3rd dose
While Hyser's Moderna side effects were a little more intense, he said they faded with some ibuprofen and a day of rest."I did, for Pfizer, have a little bit of chills, a little bit of muscle ache, but nothing that prevented me from conducting my normal day to day activities," he said, remembering how the day after his second shot in January he did some work, went grocery shopping, and made a pot of chili.
"Given the dramatic impact that [the coronavirus] has had on the world, as a scientist, it's actually really heartening that these clinical trials are still going on and the secondary and tertiary questions are still being asked," Hyser said, estimating that he'll make about $600 total (compensation for his time) over the course of this study.
- Canon’s new patent hints at a telephoto lens attachment for smartphones under development
- Kerala-based ESAF Small Finance Bank looks to raise ₹998 crore through IPO
- Meet BeachBot, a beach rover that uses AI to remove cigarette butts from beaches
- Amazon Prime Day 2021: Best deals and offers on health and household products
- Odisha’s temple town Puri becomes first Indian city with drinkable tap water available throughout the day